FDA Inspection 1084105 — Jiangxi Fushine Pharmaceutical Co., Ltd.
The FDA completed an inspection of Jiangxi Fushine Pharmaceutical Co., Ltd. on January 18, 2019 in Jing Dezhen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jing Dezhen (China)